Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gyre Therapeutics Inc (GYRE)

Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gyre Therapeutics Inc 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130 USA

www.gyretx.com Employees: 625 P: 858-567-7770

Sector:

Medical

Description:

Gyre Therapeutics Inc. is a biotechnology company. It focused on organ fibrosis and inflammatory diseases. The company's product pipeline primarily includes F573, F528 and F230. Gyre Therapeutics Inc., formerly known as Catalyst Biosciences Inc., is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 716,564
Enterprise Value, $K 679,494
Shares Outstanding, K 96,964
Float, K 87,268
% Float 90.00%
Short Interest, K 1,526
Short Float 1.57%
Days to Cover 10.82
Short Volume Ratio 0.79
% of Insider Shareholders 10.00%
% of Institutional Shareholders 23.99%

Financials:

Annual Sales, $ 116,590 K
Annual Net Income, $ 5,030 K
Last Quarter Sales, $ 37,200 K
Last Quarter Net Income, $ -1,720 K
EBIT, $ 11,490 K
EBITDA, $ 14,010 K

Growth:

1-Year Return 2.38%
3-Year Return 134.60%
5-Year Return -89.61%
5-Year Revenue Growth 456.52%
5-Year Earnings Growth 100.34%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 03/12/26
Next Earnings Date 05/08/26 [--]
Earnings Per Share ttm 0.11
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year 300.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.569 on 08/20/15
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 10/31/23

GYRE Ratios

Ratio
Price/Earnings ttm 65.82
Price/Earnings forward 57.92
Price/Earnings to Growth N/A
Return-on-Equity % 10.85%
Return-on-Assets % 9.16%
Profit Margin % 4.31%
Debt/Equity 0.00
Price/Sales 6.02
Price/Cash Flow 32.58
Price/Book 4.90
Book Value/Share 1.48
Interest Coverage -1.17
60-Month Beta 2.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.